To Evaluate the Safety, Tolerability and Analgesic Efficacy of SAF312 in Postoperative Dental Pain Patients

Phase 2 Completed 183 enrolled Novartis

RandomizedParallel-groupDouble-blindTreatment

Summary

The study will assess the analgesic efficacy and safety and tolerability of a single oral dose of SAF312 in postoperative dental pain patients after 3rd molar extraction.

Timeline

Start: 2009-09
Primary completion: 2011-03
Completion: 2011-03

Publications

Mangwani-Mordani S, Goodman CF, Galor A. Novel Treatments for Chronic Ocular Surface Pain. Cornea. 2023 Mar 1;42(3):261-271. doi: 10.1097/ICO.0000000000003193. Epub 2022 Dec 19.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Ibuprofen	Small molecule	—	—
Subject	SAF312A	Unknown	—	—

Indications

No indication recorded.